CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (2017 - 2021)
CollPlant Biotechnologies (CLGN) reported Interest Coverage Ratio of 0.39 for Q3 2021, up 579698.09% on a YoY basis from N/an in Q3 2020, and down 99.9% quarter-over-quarter from 382.88 in Q2 2021.
CollPlant Biotechnologies (CLGN) Interest Coverage Ratio (2017 - 2021) Analysis & Trends
CollPlant Biotechnologies has reported Interest Coverage Ratio for 5 years, with the latest figure at 0.39 in Q3 2021.
- For the quarter ending Q3 2021, Interest Coverage Ratio rose 579698.09% year-over-year to 0.39; the trailing twelve-month figure through Jun 2022 stood at 0.91 (up 300.11% YoY), and the FY2020 full-year result was 164.68, down 7027.85% from the prior year.
- Interest Coverage Ratio for Q3 2021 stood at 0.39, down from 382.88 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 956.5 in Q2 2020, with the low at 527.68 in Q1 2021.
- Historically, Interest Coverage Ratio has averaged 74.91 across 5 years, with a median of 0.19 in 2020.
- Annual changes were most pronounced in 2019 — Interest Coverage Ratio tumbled 5319.19% — and 2021, when it surged 579698.09%.
- CollPlant Biotechnologies' Interest Coverage Ratio stood at 22.04 in 2017, then jumped by 98.36% to 0.36 in 2018, then plunged by 54.43% to 0.56 in 2019, then decreased by 24.82% to 0.7 in 2020, then soared by 155.52% to 0.39 in 2021.
- The last three Interest Coverage Ratio figures came in at 0.39 (Q3 2021), 382.88 (Q2 2021), and 527.68 (Q1 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 382.88 |
| Mar 31, 2021 | -527.68 |
| Dec 31, 2020 | -0.70 |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | 956.50 |
| Mar 31, 2020 | 426.75 |
| Dec 31, 2019 | -0.56 |
| Sep 30, 2019 | 1.26 |
| Jun 30, 2019 | -293.50 |
| Mar 31, 2019 | -2.62 |
| Dec 31, 2018 | -0.36 |
| Sep 30, 2018 | 255.00 |
| Jun 30, 2018 | 5.62 |
| Mar 31, 2018 | 17.68 |
| Dec 31, 2017 | -22.04 |